IndraLab

Statements

Topotecan inhibits USP22. 3 / 3
| 2 1
reach
"Bortezomib, a proteasome inhibitor, but not chloroquine, an autophagy inhibitor, prevented topotecan‐induced USP22 protein degradation (Figure 6H)."
39135915
reach
"Pharmacological inhibition of USP22 by topotecan exerts a similar effect to USP22 knockout in inhibiting melanoma metastasis both in vivo and in vitro."
39135915
sparser
"Pharmacological inhibition of USP22 by topotecan exerts a similar effect to USP22 knockout in inhibiting melanoma metastasis both in vivo and in vitro."
39135915